India Operations
Market standing
Ranked 15th in the Indian pharmaceutical industry MAT August, 2023 (source: Awacs).
Leader by Rx in Diabetes & Cardiology segments.
We are the leaders in the oral anti-diabetic segment in India in terms of both prescriptions and value. It is a position we have held consistently for almost two decades. In 2022-23, we crossed the milestone of Rs. 4,000 Crs.
We are also leaders in the cardiovascular disease segment in terms of prescription generation. In terms of value, we rank fourth.
Presence:
- Diabetes
- Cardiovascular
- Vitamins / Nutritional / Minerals
- Dermatology/Cosmetology
- Gynaecology
Presence in Nutritional and Gynaecology segments through innovative products from partners in USA and Europe and in Cosmetology with a leading European brand.